We are delighted to invite you to join us in person on 1 February 2023 for our fifth Global Legacy Claims Conference.
Colleagues from our UK and US legacy disease teams will be joined by leading medical and market experts to consider some of the key challenges facing the global legacy market.
Our keynote speaker is Dr John Moore-Gillon, one of the world’s leading experts in occupational respiratory conditions, and currently Chairman of the Strategy Group overseeing the Mesothelioma Research Network set up by the British Lung Foundation, and Medical Adviser to the Department of Business, Energy and Industrial Strategy on occupational diseases of the lung.
With a particular focus on UK-wide issues, our market-leading UK disease team will share their insights on the current and future trends facing the market, and looking further afield, our US-based legacy disease team will join us to provide first-hand experience of the current trends in US litigation, particularly around Talc claims, and also the increasing surge in PFAS claims, and other “toxic torts”.
As medical and scientific advancements progress and with the increasing concern that developments in the US can be exported to other jurisdictions, keeping abreast of the emerging and future risk landscape as it impacts the legacy market is crucial.
The last time we met, a global pandemic was a theoretical risk, now, in the aftermath of Covid-19, we will look forward to what the future might hold for the legacy market, through a different lens.
12:15pm - Networking lunch
1:00pm - Conference commences
5:00pm - Drinks reception